Original Research

Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
Health Plans Must “COPE” with Chronic Diseases
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience
Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
Page 8 of 8
Results 71 - 76 of 76
Copyright © Engage Healthcare Communications, LLC. All rights reserved.